Daily Bulletin

Illuccix China Phase 3 Study Completes Enrolment

  • Written by PR Newswire Asia - Daily Bulletin Au RSS
Illuccix China Phase 3 Study Completes Enrolment

MELBOURNE, Australia and INDIANAPOLIS, May 13, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix", "the Company") today announces that the pivotal Phase 3 registration study of TLX591-CDx (Illuccix®, Kit for the preparation of 68Ga-PSMA-11) for prostate cancer imaging in Chinese patients has completed patient...

Read more: Illuccix China Phase 3 Study Completes Enrolment

Business News

Why Professional Window Cleaning Is a Must for Melbourne Homes

Let us be honest when was the last time you cleaned your windows properly? Not just a quick wipe, but a proper clean that got into all the corners, sills, and second-storey panes. If you are like mo...

Daily Bulletin - avatar Daily Bulletin

pay.com.au unlocks untapped value through Avios and British Airways partnership

British Airways joins a growing list of transfer partners including Cathay Pacific and Thai Airways, empowering SMEs with expanded redemption options and flexibility  AUSTRALIA, 29 April 2025 — p...

Daily Bulletin - avatar Daily Bulletin

Why Ignoring a Windshield Chip Could Cost You More in the Long Run

(Source) When a stone from the road jumps to your windshield, you hear the distinctive tap. You check the glass window through your reflection to discover one tiny chip that seems insignificant. A sm...

Daily Bulletin - avatar Daily Bulletin

LayBy Deals